C

CanSino Biologics
6185

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$12.23B
EV
HK$10.35B
Shares Outstanding
247.04M
Beta
1.18

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$39.80
P/E 2025E
-
P/Revenue 2025E
10.20x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About CanSino Biologics Inc.

gainify

C

CanSino Biologics Inc.

6185

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People’s Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 ...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Yu, Xuefeng

Employees

1,105

IPO Date

2019-03-28

Headquarters

401-420, Biomedical Park, 4th Floor, 185 South Avenue, TEDA West District, Tianjin 300457, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.